ZuraPrep

DRUG4 trials

Sponsors

Zurex Pharma, Inc.

Conditions

Surgical Site InfectionSurgical Skin Preparation

Phase 2

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

TerminatedNCT02221232

Zurex Pharma, Inc.Surgical Site Infection

Start: 2014-08-31End: 2014-10-31Updated: 2016-07-18

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

CompletedNCT02296645

Zurex Pharma, Inc.Surgical Site Infection

Start: 2014-11-30End: 2015-01-31Updated: 2016-07-14

Phase 3

Clinical Evaluation of Patient Preoperative Prep

CompletedNCT02831816

Zurex Pharma, Inc.Surgical Skin Preparation

Start: 2016-08-03End: 2017-08-03Updated: 2021-07-16

In-vivo Efficacy of Patient Preoperative Prep

CompletedNCT02831998

Zurex Pharma, Inc.Surgical Skin Preparation

Start: 2016-07-27End: 2017-04-09Updated: 2023-02-08

Related Papers

Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysis

Infection Control and Hospital Epidemiology2020-03-056 citations